Treatment of cancer cell lines (A431 epidermoid carcinoma, MDA-MB-231 breast carcinoma) with gefitinib (EGFR inhibitor) or camptothecin (topoisomerase inhibitor) triggered apoptosis, as evidenced by elevated levels of cleaved caspase-3. Here, EGFR is linked to cancer.